$PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Healthcare
Sector
Medical - Instruments & Supplies
Industry
Paul Arthur LaViolette
CEO
75
Employees
$19.08
Current Price
$1.60B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 2 | 2 | $13,295,337.77 | 675,233 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 2 | 2 | $13,295,337.77 | 675,233 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 2 | $13,295,337.77 | 675,233 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 2 | $13,295,337.77 | 675,233 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 2 | $13,295,337.77 | 675,233 | 12.53:1 |
| Sells | 1 | 3 | $1,061,400.00 | 45,000 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 11, 2026 | LAVIOLETTE PAUL A Director | Purchase | 15,000 | $19.69 | $295,350.00 | View Details |
| May 11, 2026 | DUGGAN ROBERT W Director | Purchase | 660,233 | $19.69 | $12,999,987.77 | View Details |
| Feb 18, 2026 | Danahy Kevin Patrick Chief Commercial Officer | Sale | 5,000 | $23.64 | $118,200.00 | View Details |
| Feb 17, 2026 | Danahy Kevin Patrick Chief Commercial Officer | Sale | 20,000 | $23.63 | $472,600.00 | View Details |
| Feb 13, 2026 | Danahy Kevin Patrick Chief Commercial Officer | Sale | 20,000 | $23.53 | $470,600.00 | View Details |
15 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.32
ActualN/A
Revenue
Estimated$250.00K
ActualN/A
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: